Japan Market Report for Surgical Robotics Systems 2017 - MedCore

  • ID: 4085800
  • Report
  • Region: Japan
  • 475 pages
  • iData Research
15 % OFF
until Oct 31st 2018
1 of 4

FEATURED COMPANIES

  • Brainlab
  • Karl Storz
  • Medtronic
  • Stryker
  • MORE
General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends

- Market Drivers & Limiters for each chapter segment

- Competitive Analysis for each chapter segment

- Section on recent mergers & acquisitions

The domestic Japanese surgical robotics industry has been slow to develop, chiefly due to strict regulatory controls which have dissuaded companies from making investments in this area of research. The Japanese government announced a policy shift in 2014, in particular a restructuring of the approval process to make it more efficient. This has encouraged greater interest in developing domestic robotic options, including in surgery. It is expected that more Japanese companies will invest in this area throughout the forecast period.

The best example of surgeon-controlled robotics designed for minimally invasive surgery (MIS) is the da Vinci® system from Intuitive Surgical. This system involves highly sophisticated robotic arms that assist in MIS procedures. The surgical arms and the instruments they are equipped with are smaller than surgeon’s hands, and are capable of performing very delicate MIS procedures. The surgeon must control the robotic arms through a workstation using real time video and other feedback from the robot. The da Vinci® system is moving toward becoming the standard of care for prostatectomy and has been used for dozens of other procedures. Currently, it is by far the most successful surgical robotic system in the Japanese and global markets. The New Energy and Industrial Technology Development Organization (NEDO), a public Japanese agency which operates as an Independent Administrative Institution, intends to develop a system to compete with the da Vinci®.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Brainlab
  • Karl Storz
  • Medtronic
  • Stryker
  • MORE
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

2. Disease Overview
2.1 Medical Conditions
2.1.1 Neurosurgery Conditions
2.1.1.1 Hydrocephalus
2.1.1.2 Communicating Hydrocephalus
2.1.1.3 Normal Pressure Hydrocephalus
2.1.1.4 Non-Communicating Hydrocephalus
2.1.1.5 Brain Tumor
2.1.1.6 Intracranial Pressure
2.1.1.7 Intracranial Aneurysm
2.1.1.8 Intracranial Atherosclerosis Disease
2.1.2 Spinal Conditions
2.1.2.1 Herniated Disc
2.1.2.2 Spinal Stenosis
2.1.2.3 Spondylosis
2.1.2.4 Scoliosis
2.1.2.5 Lordosis
2.1.2.6 Kyphosis
2.1.3 ENT Conditions
2.1.3.1 Otitis Media
2.1.3.2 Cholesteatomas
2.1.3.3 Otosclerosis
2.1.3.4 Chronic Sinusitis
2.1.3.5 Tonsillitis
2.1.4 Orthopedic Conditions
2.1.4.1 Fractures
2.1.4.2 Osteoporosis
2.1.4.3 Arthritis
2.1.5 Gynecological Conditions
2.1.5.1 Gynecological Cancers
2.1.5.2 Uterine Fibroids
2.1.5.3 Endometriosis
2.1.5.4 Menorrhagia
2.1.5.5 Pelvic Prolapse
2.1.6 Urological Conditions
2.1.6.1 Prostate Cancer
2.1.6.2 Bladder Cancer
2.1.6.3 Kidney Cancer
2.1.6.4 Benign Prostate Hyperplasia (BPH)
2.1.7 Digestive Tract Conditions
2.1.7.1 Achalasia
2.1.7.2 Stomach Cancer
2.1.7.3 Hernia
2.1.7.4 Gallbladder Attack
2.1.7.5 Gastroesophageal Reflex Disease
2.1.8 Colorectal Conditions
2.1.8.1 Colorectal Cancer
2.1.8.2 Inflammatory Bowel Disease
2.1.8.3 Diverticulitis
2.1.9 Cardiac Conditions
2.1.9.1 Mitral Valve Prolapse
2.1.9.2 Coronary Artery Disease

3. Product Assessment
3.1 Robotic Assisted Surgery Product Portfolios
3.1.1 Robotic-Assisted Surgery Overview
3.1.2 Neurosurgery
3.1.3 Spine Surgery
3.1.4 Orthopedic Surgery
3.2 Ras Regulatory Issues And Recalls
3.2.1 Accuray Inc.
3.2.2 Blue Belt Technologies
3.2.3 Hansen Medical Inc.
3.2.4 Intuitive Surgical
3.2.5 Mako Surgical/Stryker
3.2.6 Omnilife Science
3.3 Clinical Trials
3.4 Ras Clinical Trials
3.4.1 Accuray Inc.
3.4.2 Catheter Precision
3.4.3 Corindus Inc
3.4.4 Hansen Medical
3.4.5 Intuitive Surgical
3.4.6 Mako Surgical/Stryker
3.4.7 Mazor
3.4.8 Medrobotics
3.4.9 Medtech

4. Surgical Robotics Market
4.1 Introduction
4.2 Minimally Invasive Surgery Robotic Device Market
4.2.1 Introduction
4.2.2 Market Analysis And Forecast
4.2.3 Drivers And Limiters
4.2.3.1 Market Drivers
4.2.3.2 Market Limiters
4.2.4 Leading Competitors
4.2.5 Emerging Competitors
4.3 Robotic Radiosurgery Device Market
4.3.1 Introduction
4.3.2 Market Analysis And Forecast
4.3.3 Drivers And Limiters
4.3.3.1 Market Drivers
4.3.3.2 Market Limiters
4.3.4 Leading Competitors

List of Charts

Chart 1 1: Robotics And Surgical Navigation Market By Segment, Japan, 2013 - 2023
Chart 1 2: Robotics And Surgical Navigation Market Overview, Japan, 2016 & 2023
Chart 4 1: Minimally Invasive Surgery Robotic Device Market, Japan, 2013 - 2023
Chart 4 2: Robotic Radiosurgery Device Market, Japan, 2013 - 2023

List of Figures

Figure 1 1: Robotics And Surgical Navigation Systems Competitor Market Share Ranking By Segment, Japan, 2016 (1 Of 2)
Figure 1 2: Robotics And Surgical Navigation Systems Competitor Market Share Ranking By Segment, Japan, 2016 (2 Of 2)
Figure 1 3: Companies Researched In This Report, Japan, 2016
Figure 1 4: Factors Impacting The Robotics And Surgical Navigation Systems Market By Segment, Japan (1 Of 2)
Figure 1 5: Factors Impacting The Robotics And Surgical Navigation Systems Market By Segment, Japan (2 Of 2)
Figure 1 6: Recent Events In The Robotics And Surgical Navigation Market, Japan, 2013 - 2016
Figure 1 7: Robotics And Surgical Navigation Systems Markets Covered, Japan, 2016
Figure 1 8: Key Report Updates
Figure 1 9: Version History
Figure 3 1: Robot-Assisted Neurosurgery Products By Company
Figure 3 2: Robot-Assisted Spine Surgery Products By Company
Figure 3 3: Robot-Assisted Orthopedic Surgery Products By Company
Figure 3 4: Class 2 Device Recall Accuray Inc
Figure 3 5: Class 2 Device Recall Accuray Inc
Figure 3 6: Class 2 Device Recall Accuray Inc
Figure 3 7: Class 2 Device Recall Accuray Inc
Figure 3 8: Class 2 Device Recall Accuray Inc
Figure 3 9: Class 2 Device Recall Accuray Inc
Figure 3 10: Class 2 Device Recall Blue Belt Technologies
Figure 3 11: Class 2 Device Recall Blue Belt Technologies
Figure 3 12: Class 2 Device Recall Blue Belt Technologies
Figure 3 13: Class 2 Device Recall Hansen Medical
Figure 3 14: Class 2 Device Recall Hansen Medical
Figure 3 15: Class 2 Device Recall Hansen Medical
Figure 3 16: Class 2 Device Recall Intuitive Surgical
Figure 3 17: Class 2 Device Recall Intuitive Surgical
Figure 3 18: Class 2 Device Recall Intuitive Surgical
Figure 3 19: Class 2 Device Recall Intuitive Surgical
Figure 3 20: Class 2 Device Recall Intuitive Surgical
Figure 3 21: Class 2 Device Recall Intuitive Surgical
Figure 3 22: Class 2 Device Recall Intuitive Surgical
Figure 3 23: Class 2 Device Recall Intuitive Surgical
Figure 3 24: Class 2 Device Recall Intuitive Surgical
Figure 3 25: Class 2 Device Recall Intuitive Surgical
Figure 3 26: Class 2 Device Recall Intuitive Surgical
Figure 3 27: Class 2 Device Recall Intuitive Surgical
Figure 3 28: Class 2 Device Recall Intuitive Surgical
Figure 3 29: Class 2 Device Recall Intuitive Surgical
Figure 3 30: Class 2 Device Recall Intuitive Surgical
Figure 3 31: Class 2 Device Recall Intuitive Surgical
Figure 3 32: Class 2 Device Recall Intuitive Surgical
Figure 3 33: Class 2 Device Recall Intuitive Surgical
Figure 3 34: Class 2 Device Recall Intuitive Surgical
Figure 3 35: Class 2 Device Recall Intuitive Surgical
Figure 3 36: Class 2 Device Recall Intuitive Surgical
Figure 3 37: Class 2 Device Recall Intuitive Surgical
Figure 3 38: Class 2 Device Recall Intuitive Surgical
Figure 3 39: Class 2 Device Recall Intuitive Surgical
Figure 3 40: Class 2 Device Recall Intuitive Surgical
Figure 3 41: Class 2 Device Recall Intuitive Surgical
Figure 3 42: Class 2 Device Recall Intuitive Surgical
Figure 3 43: Class 2 Device Recall Intuitive Surgical
Figure 3 44: Class 2 Device Recall Intuitive Surgical
Figure 3 45: Class 2 Device Recall Intuitive Surgical
Figure 3 46: Class 2 Device Recall Intuitive Surgical
Figure 3 47: Class 2 Device Recall Intuitive Surgical
Figure 3 48: Class 2 Device Recall Intuitive Surgical
Figure 3 49: Class 2 Device Recall Intuitive Surgical
Figure 3 50: Class 2 Device Recall Intuitive Surgical
Figure 3 51: Class 2 Device Recall Intuitive Surgical
Figure 3 52: Class 2 Device Recall Intuitive Surgical
Figure 3 53: Class 2 Device Recall Intuitive Surgical
Figure 3 54: Class 2 Device Recall Intuitive Surgical
Figure 3 55: Class 2 Device Recall Intuitive Surgical
Figure 3 56: Class 2 Device Recall Intuitive Surgical
Figure 3 57: Class 2 Device Recall Intuitive Surgical
Figure 3 58: Class 2 Device Recall Intuitive Surgical
Figure 3 59: Class 2 Device Recall Intuitive Surgical
Figure 3 60: Class 2 Device Recall Intuitive Surgical
Figure 3 61: Class 2 Device Recall Mako Surgical/Stryker
Figure 3 62: Class 2 Device Recall Mako Surgical/Stryker
Figure 3 63: Class 2 Device Recall Mako Surgical/Stryker
Figure 3 64: Class 2 Device Recall Mako Surgical/Stryker
Figure 3 65: Class 2 Device Recall Mako Surgical/Stryker
Figure 3 66: Class 2 Device Recall Mako Surgical/Stryker
Figure 3 67: Class 2 Device Recall Omnilife Science, Inc
Figure 3 68: Class 2 Device Recall Omnilife Science, Inc
Figure 3 69: Class 2 Device Recall Omnilife Science, Inc
Figure 3 70: Class 2 Device Recall Omnilife Science, Inc
Figure 3 71: Class 2 Device Recall Omnilife Science, Inc
Figure 3 72: Endoscopic Evaluation Of Late Rectal Injury Following Cyberknife Radiosurgery For Prostate Cancer
Figure 3 73: Cyberknife Stereotactic Radiosurgery For Low And Intermediate Risk Prostate Cancer
Figure 3 74: A Phase Ii Trial Of Cyberknife Stereotactic Radiosurgery To Prostate Tumors
Figure 3 75: Study To Establish Maximum Tolerated Dose (Mtd) Of Cyberknife In Patients
Figure 3 76: A Phase Ii Trial Of Cyberknife Radiosurgery To Perioptic Tumors
Figure 3 77: Evaluation Of Cyberknife Stereotactic Radiotherapy In Prostate Cancer
Figure 3 78: An Effectiveness And Toxicity Of Cyberknife Based Radiosurgery For Parkinson Disease
Figure 3 79: Cyberknife Stereotactic Accelerated Partial Breast Irradiation (Sapbi) (Ck-Sapbi)
Figure 3 80: Safety And Efficacy Study Of Five-Fraction Stereotactic Body Radiation Therapy
Figure 3 81: A Study Of Pre-Operative Cyberknife In Patients With Potentially Resectable Pancreas Cancer
Figure 3 82: Stereotactic Radiosurgery For Soft Tissue Sarcoma
Figure 3 83: A Phase Ii Study Of Cyberknife Radiosurgery For Renal Cell Carcinoma
Figure 3 84: Safety And Feasibility Of Arrhythmia Ablation Using The Amigo Remote Robotic System
Figure 3 85: Evaluation Of The Amigo Robotic System For Ablation Of The Cavo-Tricuspid Isthmus
Figure 3 86: Manual Vs Amigo Smarttouch Atrial Fibrillation Study (Mast-Af)
Figure 3 87: Robotic-Assisted Peripheral Intervention For Peripheral Arterial Disease (Rapid)
Figure 3 88: Robotic-Assisted Peripheral Intervention For Peripheral Arterial Disease Ii (Rapid Ii)
Figure 3 89: Post-Market Corpath Registry On The Corpath 200 System
Figure 3 90: Embolization Procedures In The Peripheral Vasculature Using The Magellan™ Robotic System
Figure 3 91: Registry Of The Magellan Robotic System (Rover)
Figure 3 92: Evaluation Of Clinical Outcomes In Robotic-Assisted Inguinal Hernia Repair
Figure 3 93: A Retrospective Multicenter Investigation Of The Use Of The Da Vinci® Surgical System
Figure 3 94: Cosmesis, Patient Satisfaction And Quality Of Life After Da Vinci
Figure 3 95: Robotic-Assisted Versus Laparoscopic Sigmoid Resection
Figure 3 96: Prospective Investigation Of Robotic Single-Port System
Figure 3 97: Clinical Outcomes Of Knee Replacement
Figure 3 98: A Trial Evaluating Tkr Compared To Bkr Performed Using Stryker's Mako Robot
Figure 3 99: Robotic Arm Assisted Total Knee Arthroplasty
Figure 3 100: Outcomes Of Robotic Total Hip Arthroplasty
Figure 3 101: Clinical And Economic Comparison Of Robot Assisted Versus Manual Knee Replacement
Figure 3 102: Prospective, Observational Registry Of Renaissance-Guided Spine Surgeries
Figure 3 103: Clinical Trial Of Minimally Invasive Robotic Spine Surgery
Figure 3 104: Robotic Vs. Freehand Corrective Surgery For Pediatric Scoliosis (Pedscoli)
Figure 3 105: Address - Adult Deformity Robotic Vs. Freehand Surgery To Correct Spinal Deformity
Figure 3 106: Mis Refresh: Robotic Vs. Freehand Minimally Invasive Spinal Surgeries
Figure 3 107: A Post-Market Clinical Trial For Access And Visualization
Figure 3 108: Robotic-Assisted Pedicule Screw Placement (Arass)
Figure 4 1: Minimally Invasive Surgery Robotic Device Market, Japan, 2013 - 2023 (Us$)
Figure 4 2: Minimally Invasive Surgery Robotic Device Market, Japan, 2013 - 2023 (Jp¥)
Figure 4 3: Drivers And Limiters, Minimally Invasive Surgery Robotic Device Market, Japan, 2016
Figure 4 4: Leading Competitors, Orthopedic Navigation System Market, Japan, 2016
Figure 4 5: Robotic Radiosurgery Device Market, Japan, 2013 - 2023 (Us$)
Figure 4 6: Robotic Radiosurgery Device Market, Japan, 2013 - 2023 (Jp¥)
Figure 4 7: Drivers And Limiters, Robotic Radiosurgery Device Market, Japan, 2016
Figure 4 8: Leading Competitors, Robotic Radiosurgery Device Market, Japan, 2016
Figure 6 1: Press Release Summary
Figure 6 2: Press Release Summary
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Brainlab
  • Medtronic
  • Stryker
  • Karl Storz
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll